Talon Therapeutics, Inc. Reports Fourth Quarter and Year End 2010 Financial Results
March 28, 2011 09:00 ET
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., March 28, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) today reported financial results for the fourth quarter and full year ended December 31, 2010, and provided...
Talon Therapeutics to Host a Conference Call to Report Fourth Quarter and Full Year 2010 Results and Business Update on March 28, 2011
March 24, 2011 19:49 ET
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., March 24, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) will host a conference call on Monday, March 28, 2011 at 8am PT, to include a discussion of results and...
Talon Therapeutics to Present at the Roth Capital Partners 23rd Annual OC Growth Stock Conference
March 14, 2011 08:30 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., March 14, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics (OTCBB:TLON), announced that Steven R. Deitcher, M.D., President and Chief Executive Officer, is scheduled to present...
New Patent Issued for Talon Therapeutics' Marqibo(R) Expands Disease Coverage to Include Lymphoma, Leukemia and Myeloma
March 10, 2011 08:30 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., March 10, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON), today announced the issuance of U.S. patent 7,887,836 B2, which covers compositions and methods...
Hana Biosciences to Change Name to Talon Therapeutics
December 01, 2010 08:30 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 1, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, announced that its...
Hana Biosciences to Present Data on Marqibo(R) at the 2010 American Society of Hematology Annual Meeting and Exposition
November 29, 2010 09:00 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 29, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
Hana Biosciences Reports Third Quarter 2010 Financial Results
November 12, 2010 09:00 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences, Inc. (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported...
Hana Biosciences to Host a Conference Call to Report Third Quarter 2010 Results and Business Update on November 12, 2010
November 08, 2010 17:23 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 8, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences, Inc. (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, will host a...
Hana Biosciences Reverse Stock Split Effective Monday, September 13, 2010
September 10, 2010 16:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 10, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences, Inc. (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced...
Hana Biosciences Reports Second Quarter 2010 Financial Results
August 13, 2010 06:15 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 13, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences Inc. (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported...